Intraday Overview | The three major indices of Hong Kong stocks weakened slightly, and the pharmaceutical outsourcing concept rose against the market
Road transport stocks strengthened; Guangzhou-Shenzhen Railway shares rose more than 9%, Anhui Wantong Expressway rose more than 6%; domestic housing stocks collectively pulled back, Agile Group fell more than 6%, and Midea Real Estate fell more than 5%.
維亞生物:2023年度報告
Multiple arrows in unison! Pharmaceutical innovation support policies are coming
Recently, many places, including Beijing, Guangzhou, and Zhuhai, have successively issued relevant policies (draft for comments) to support the high-quality development of the biomedical industry or innovative pharmaceutical devices. The intensive introduction of support policies and the tight schedule have attracted great attention from the industry.
Viva Biotech (01873) announced annual results, losses attributable to shareholders of 116 million yuan narrowed by 78.03% year-on-year
Viva Biotech (01873) announced its annual results for the year ended December 31, 2023, with group revenue of RMB 21...
VIVA BIOTECH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023 AND PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
Hong Kong pharmaceutical stocks bucked the trend, and Pharmacovigilance led their sector. Is the “Biosafety Act” or a biological variable?
① Why is the market paying attention to the Biosafety Act? ② How has Yao Ming Kangde performed recently?
Viva Biotech (01873.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 ViaBio (01873.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
VIVA BIOTECH: DATE OF BOARD MEETING
Yao Ming Kangde was removed from BIO membership! Where will the domestic innovative drug sector go?
The path to the rise of innovative drugs doesn't seem easy!
Not only is Daimo bullish, but Xiaoma has taken steps to increase its holdings of the drug Ming Kangde. Major international banks are turning one after another, and the Hong Kong stock pharmaceutical industry is welcoming a “crouching and leap”?
① Hong Kong stocks of Innovative Pharmaceuticals soared at the end of yesterday. Collumbotai Biotech B rose 14.9%; Rongchang Biotech rose 14.8%; Connoya B rose 12.8%; ② Although “Yao Mao” Pharmaceutical Kangde Hong Kong shares closed down 1.16%, the decline narrowed sharply at the end of the session, and J.P. Morgan increased its holdings by 1.654 million shares, or HK$77.68 million.
A major favorable raid, and the 1.6 trillion innovative drug sector is booming!
The advantage suddenly “smashed” into the pharmaceutical sector!
Express News | China Artificial Intelligence Industry Development Alliance plans to initiate the establishment of a “Biomedical Industry Working Group”
The US Senate version of the Biosafety Act was passed at a hearing last night. What is the situation, and how should the Pharmacovigilance Department respond?
The industry believes that the bill may be fiercely discussed and repeatedly revised in the Senate and House of Representatives, and that relevant companies should “think from the bottom line.”
A quick overview of the Hong Kong market | The Hang Seng Index rose nearly 2%, and the Science Index rose nearly 3%; insurance, real estate and other sectors were strong throughout the day
Technet stocks were strong. Meituan rose nearly 5%, Bilibili and Kuaishou rose more than 3%, Xiaomi and Jingdong rose more than 2%, Baidu, Ali, and Tencent rose more than 1%, and NetEase followed; insurance stocks were strong throughout the day. China Ping An rose more than 6%, China Life Insurance rose nearly 5%, and AIA Insurance rose more than 2%.
A quick overview of the Hong Kong market | The three major indices picked up in the afternoon, and the medical sector performed well. Pharmaceuticals and Ming Union rose more than 17%, and minimally invasive medicine rose more than 15%
Technology Network stocks had mixed ups and downs. Kuaishou and Bilibili rose more than 1%, Meituan, Ali, NetEase, and Baidu rose slightly, and JD and Tencent fell slightly; the decline in auto stocks narrowed, with Xiaopeng Motors falling nearly 4%, Great Wall Motors falling nearly 3%, BYD shares falling more than 2%, and Ideal Auto closing up nearly 1%.
Yao Ming Biotech rose more than 9% and continued to lead biomedical stocks. Has the negative run come to an end?
① Why does the biomedical sector continue to strengthen? ② Have the factors bothering CRO concept stocks been resolved?
Intraday Overview | The three major indices rose slightly, and the Tech Index rose nearly 2%; auto stocks and biotech stocks rose strongly. NIO rose nearly 8%, and Pharmaceutical Biotech rose more than 9%
Most Technology Network stocks rose, with Station B up more than 4%; Meituan and NetEase up more than 3%; mobile phone equipment stocks showed active performance, with Shunyu Optical Technology up more than 7% and Gaowei Electronics by more than 5%; pharmaceutical distribution stocks improved, Ali Health rose more than 8%, and JD Health rose nearly 5%.
Changes in Hong Kong stocks | CRO concept stocks collectively rise, US biosafety draft storm suspends, Pharmacomingkant completes 1 billion repurchases in a single day
The Zhitong Finance App learned that CRO concept stocks rose collectively. As of press release, Viva Biotech (01873) rose 6.78% to HK$0.63; Gloria Ying (06821) rose 5.33% to HK$64.25; Pharmaceutical Kangde (02359) rose 4.29% to HK$47.4; Kanglong Chemical (03759) rose 3.61% to HK$9.48; Pharmaceutical Biotech (02269) rose 1.5% to HK$17.56. According to the news, Yao Ming Kangde announced that on February 5, the company bought back 2,0754 million A shares for the first time, at a price of 46.5-
Express News | Foreign media: US Senate postpones review of the biotechnology-related Chinese enterprise bill
Intraday Overview | The Tech Index fell more than 2%, Apple concept stocks and pharmaceutical stocks had the highest declines, and Shunyu Optical Technology fell more than 8%
Technet stocks collectively weakened, with Xiaomi falling nearly 4%, Meituan falling nearly 3%, and Kuaishou falling more than 2%; domestic housing stocks continued to decline, with Country Garden falling more than 3%; Longhu Group, Xincheng Development, and Sunac China falling nearly 2%; auto stocks were weak, with Zero Sports Auto and NIO falling more than 5%, and Xiaopeng Motors falling more than 4%.
No Data